Status:
COMPLETED
Oral Tranexamic Acid Plus Sublingual Misoprostol in Atonic Postpartum Hemorrhage
Lead Sponsor:
Aswan University Hospital
Conditions:
Post Partum Hemorrhage
Eligibility:
FEMALE
20-40 years
Phase:
NA
Brief Summary
The aim of the study is to evaluate the effect of oral tranexamic acid plus, sublingual misoprostol in the management of atonic postpartum hemorrhage (PPH) after vaginal delivery
Detailed Description
Uterine atony is the main cause of PPH; therefore, active management of the third stage of labor has emerged as a most actual tool in its prevention. The previous study in Egypt recorded that 88% of d...
Eligibility Criteria
Inclusion
- All participants had PPH defined as vaginal bleeding\>500 ml after vaginal delivery and uterine atony confirmed by abdominal palpation.
Exclusion
- were gestational age\<37 weeks,
- genital tract trauma,
- coagulation defect,
- women with hypertension, preeclampsia, cardiac, renal or liver diseases, epilepsy
- known hypersensitivity to carbetocin or oxytocin.
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
135 Patients enrolled
Trial Details
Trial ID
NCT03870256
Start Date
April 1 2019
End Date
September 1 2021
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
AswanUH
Aswān, Egypt, 81528